In contrast, DKA, in the context of T1D is more common, with or without the use of SGLT2 inhibitors, but off-label use of SGLT2 inhibitors, especially among young females was a risk factor [92]. This evidence concerns the gene SLC5A2 and type 1 diabetes mellitus.